McLeod J R, Shen M, Kim D J, Thayer S A
Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA.
J Neurophysiol. 1998 Nov;80(5):2688-98. doi: 10.1152/jn.1998.80.5.2688.
Reducing the extracellular Mg2+ concentration ([Mg2+]o) to 0.1 mM evoked an aberrant pattern of glutamatergic activity in the synaptic network formed by rat hippocampal neurons grown in primary culture. This treatment resulted in a significant increase in neuronal death when maintained for 20-24 h; 0.1 mM [Mg2+]o elicited a stable and repetitive series of intracellular Ca2+ concentration ([Ca2+]i) spikes as indicated by indo-1-based microfluorimetry. Fura-2-based digital imaging experiments found that the [Ca2+]i spikes were synchronized for all the neurons in a given field. Thus electrophysiological recordings from individual cells were reasonable representations of the field as a whole, enabling correlation of electrical activity to viability. Underlying each [Ca2+]i spike was an intense burst of action potentials. Whole cell voltage-clamp experiments showed that a burst was composed of fast action currents superimposed on a slow inward current. The N-methyl--aspartate (NMDA) receptor antagonist CGS19755 (10 microM) blocked [Ca2+]i spiking, the slow inward current, and the cell death induced by low [Mg2+]o. The L-type Ca2+ channel antagonist nimodipine (10 microM) blocked [Ca2+]i spiking, all synaptic activity, and the cell death induced by low [Mg2+]o. The non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 microM) exerted variable effects on [Ca2+]i spiking and blocked the slow inward current only when the cells were held at a relatively negative holding potential. CNQX did not afford any protection from 0.1 mM [Mg2+]o-induced neurotoxicity. [Ca2+]i imaging experiments showed that CNQX inhibited [Ca2+]i spiking in a subset of neurons within an active network. Thus, the neurons that were insensitive to CNQX appear to be those that were destined to die. We characterized an in vitro model that allowed us to correlate specific electrophysiological components of glutamatergic synaptic activity to the subsequent viability of the network. A slow NMDA receptor-mediated inward current was required to elicit [Ca2+]i spiking and neurotoxicity. Non-NMDA receptors did not contribute to synaptically mediated cell death in this model. An L-type Ca2+ channel antagonist was neuroprotective when used at concentrations that blocked synaptic activity, suggesting that dendritic L-type Ca2+ channels present a useful target for neuroprotective drugs.
将细胞外镁离子浓度([Mg2+]o)降至0.1 mM,可诱发原代培养的大鼠海马神经元形成的突触网络中谷氨酸能活动的异常模式。这种处理在维持20 - 24小时后导致神经元死亡显著增加;0.1 mM [Mg2+]o引发了一系列稳定且重复的细胞内钙离子浓度([Ca2+]i)尖峰,基于indo - 1的显微荧光测定法表明了这一点。基于fura - 2的数字成像实验发现,给定视野内所有神经元的[Ca2+]i尖峰是同步的。因此,来自单个细胞的电生理记录合理地代表了整个视野,使得电活动与细胞活力能够相互关联。每个[Ca2+]i尖峰的基础是一阵强烈的动作电位爆发。全细胞电压钳实验表明,一阵爆发由叠加在缓慢内向电流上的快速动作电流组成。N - 甲基 - D - 天冬氨酸(NMDA)受体拮抗剂CGS19755(10 microM)阻断了[Ca2+]i尖峰、缓慢内向电流以及低[Mg2+]o诱导的细胞死亡。L型钙离子通道拮抗剂尼莫地平(10 microM)阻断了[Ca2+]i尖峰、所有突触活动以及低[Mg2+]o诱导的细胞死亡。非NMDA受体拮抗剂6 - 氰基 - 7 - 硝基喹喔啉 - 2,3 - 二酮(CNQX,10 microM)对[Ca2+]i尖峰产生可变影响,并且仅当细胞保持在相对负的钳制电位时才阻断缓慢内向电流。CNQX不能为0.1 mM [Mg2+]o诱导的神经毒性提供任何保护。[Ca2+]i成像实验表明,CNQX在活跃网络中的一部分神经元中抑制了[Ca2+]i尖峰。因此,对CNQX不敏感的神经元似乎就是那些注定要死亡的神经元。我们表征了一个体外模型,该模型使我们能够将谷氨酸能突触活动的特定电生理成分与随后的网络活力相互关联。需要一个缓慢的NMDA受体介导的内向电流来引发[Ca2+]i尖峰和神经毒性。在这个模型中,非NMDA受体对突触介导的细胞死亡没有作用。当L型钙离子通道拮抗剂以阻断突触活动的浓度使用时具有神经保护作用,这表明树突状L型钙离子通道是神经保护药物的一个有用靶点。